As part of its long-term investment in women’s sports, Eli Lilly will be present at the WNBA All-Star Game through breast cancer awareness activations.

A weekend focused on women’s health and women’s basketball, all in Eli Lilly’s home state of Indiana? Consider that a layup ...

Eli Lilly LLY announced results from the phase III EMBER-3 study, which showed that treatment with its orally administered investigational drug imlunestrant significantly reduced the risk of ...

Imlunestrant in combination with Eli Lilly’s Verzenio (abemaciclib) reduced the risk of progression or death by 43% versus imlunestrant alone, in all patients.

Cancer conversations are evolving beyond awareness months, with increased focus on personal journeys, breakthroughs and patient experiences.

Lilly Pulitzer's sixth annual collection to benefit the Breast Cancer Research Foundation features the Absolutely Flamazing pattern, which is a pink-and-white paisley and flamingo pattern that ...

A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.

Eli Lilly (LLY) reported positive Phase 3 data for its drug candidate imlunestrant as both a combination and monotherapy in the treatment of advanced breast cancer. Read more here.

This article Eli Lilly's Investigational Cancer Drug Cuts Risk Of Death By 38% In Breast Cancer Patients originally appeared on Benzinga.com ...

Data from a late-stage study shows that LLY's experimental oral drug benefited certain breast cancer patients when used as both a combination and monotherapy.